BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center For Technology Licensing
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250604T120000
DTEND;TZID=America/New_York:20250604T130000
DTSTAMP:20260411T201508
CREATED:20250522T180747Z
LAST-MODIFIED:20250523T150247Z
UID:10000568-1749038400-1749042000@ctl.cornell.edu
SUMMARY:Lab to Impact: Healthcare Module - From Bench to Market: Navigating the Complex Landscape of Drug Commercialization
DESCRIPTION:Join the Center for Technology Licensing for a dynamic panel on the real-world path from innovation to therapeutic impact. \nIndustry leaders and biotech entrepreneurs\, including Weill Cornell inventors and founders of licensed startup Convergent Therapeutics\, will share an insightful discussion on navigating the path from the laboratory to the patient in the drug development space. Whether you’re considering commercialization or actively developing potential new drugs\, this panel offers valuable perspectives on turning promising research into new therapies. \nOur expert panelists will share practical insights from every stage of the process—from discovery and development\, preclinical research\, and clinical trials to FDA review and post-market safety monitoring. You’ll gain a better understanding of how regulatory strategy and market access shape the journey\, and how successful teams overcome common barriers to bring therapeutics to market. \nWhat to expect: \n\nKey insights into regulatory and market access strategy\nLessons from successful therapeutic launches\nReal-world examples of collaboration and adaptation\nExpert perspectives across the full drug development lifecycle\n\nGuest speakers:  \n\nAlexander Brown\, COO of Convergent Therapeutics\nDr. Neil Bander\, CSO\, Co-Founder of Convergent Therapeutics\nDr. Philip Kantoff\, CEO\, Co-Founder of Convergent Therapeutics\nDr. Scott Tagawa\, Professor of Medicine in Urology at Weill Cornell Medicine \n\nHosted by Brian Kelly\, Director of Technology Licensing\, CTL at Weill Cornell Medicine \nWhether you’re considering a new idea\, commercialization\, or actively developing a technology\, this event offers valuable perspectives on turning promising research into market-ready solutions.
URL:https://ctl.cornell.edu/event/navigating-the-complex-landscape-of-drug-commercialization
CATEGORIES:CTL Events
END:VEVENT
END:VCALENDAR